Please select a Capability in order to start your service request.
Choose the syringe that makes a difference they can feel
The BD insulin syringe with the BD Ultra-Fine™ 6mm™ needle features our shortest insulin syringe needle, at 53% shorter than the 12.7-mm needle. This length is supported by the latest recommendations published in Mayo Clinic Proceedings that advocate using the shortest needle first-line for all patient categories.1* In fact, in a 2010 study, 80% of patients preferred shorter needles compared to 8-mm and 12.7-mm needles.2 They also deliver insulin into the subcutaneous tissue, reducing the risk of painful intramuscular (IM) injection.3
Four barrel sizes
The insulin syringe comes in four different barrel sizes and scale capacities to optimize dose.
Reduced risk of hypoglycemia
Longer needle lengths may lead to frequent IM vs subcutaneous tissue injections, which may cause unexplained hypoglycemia.1,3
|BD insulin syringe with BD Ultra-Fine 6mm needle|
|Catalog no.||BD NDC/HRI no.||Syringe size||e-catalog|
|324912||08290-3249-12||1 mL 6 mm (15/64 in) x 31 G|
|324911||08290-3249-11||1/2 mL 6 mm (15/64 in) x 31 G|
|324909||08290-3249-09||3/10 mL 6mm (15/64 in) x 31 G|
* Use of syringe needles in very young children (< 6 years old) and extremely thin adults (with a BMI of < 19) is not recommended, even if they use a raised skinfold, because of the excessively high risk of IM injections. When any syringe needle is used in children (≥ 6 years old), adolescents, or slim to normal-weight adults (with a BMI of 19 to 25 [calculated as the weight in kilograms divided by the height in meters squared]), injections should always be given into a lifted skinfold.